7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Williamson E et al. | Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. | 2002 | J. Immunol. | pmid:12244151 |
| Ferrer Cañabate J et al. | [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. | 2002 | An Med Interna | pmid:12244784 |
| Chen XW et al. | Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12150965 |
| Katagiri T and Takahashi N | Regulatory mechanisms of osteoblast and osteoclast differentiation. | 2002 | Oral Dis | pmid:12108759 |
| Lee SK and Lorenzo JA | Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. | 2002 | Bone | pmid:12110442 |
| Shioi A et al. | Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. | 2002 | Circ. Res. | pmid:12114316 |
| Lipton A et al. | Serum osteoprotegerin levels in healthy controls and cancer patients. | 2002 | Clin. Cancer Res. | pmid:12114435 |
| Fujita T et al. | SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells. | 2002 | J. Oral Pathol. Med. | pmid:12201246 |
| Juji T et al. | A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders. | 2002 | J. Bone Miner. Metab. | pmid:12203031 |
| Grisar J et al. | Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. | 2002 | J. Rheumatol. | pmid:12136902 |
| Hofbauer LC et al. | Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. | 2002 | Eur. J. Endocrinol. | pmid:12153751 |
| Mundy GR | Metastasis to bone: causes, consequences and therapeutic opportunities. | 2002 | Nat. Rev. Cancer | pmid:12154351 |
| Lorget F et al. | Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12163011 |
| Ulrich-Vinther M et al. | Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. | 2002 | J Bone Joint Surg Am | pmid:12177271 |
| Ohmori H et al. | Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. | 2002 | J. Hum. Genet. | pmid:12181640 |
| Armstrong AP et al. | A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. | 2002 | J. Biol. Chem. | pmid:12185073 |
| Schoppet M et al. | RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. | 2002 | Arterioscler. Thromb. Vasc. Biol. | pmid:11950689 |
| Hasegawa T et al. | Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. | 2002 | Tissue Cell | pmid:11989970 |
| Evdokiou A et al. | Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. | 2002 | Int. J. Cancer | pmid:11992538 |
| Corey E et al. | Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. | 2002 | Prostate | pmid:11992617 |
| Gruber R et al. | Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. | 2002 | Bone | pmid:11996911 |
| de Hooge AS et al. | Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. | 2002 | Am. J. Pathol. | pmid:12000725 |
| Inoue D and Matsumoto T | [Recent advances in basic research of bone metabolism]. | 2002 | Nippon Rinsho | pmid:11979916 |
| Ono K et al. | Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. | 2002 | J. Bone Miner. Res. | pmid:12009007 |
| Iida-Klein A et al. | Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. | 2002 | J. Bone Miner. Res. | pmid:12009011 |
| Jain RG and Lenhard JM | Select HIV protease inhibitors alter bone and fat metabolism ex vivo. | 2002 | J. Biol. Chem. | pmid:11937496 |
| Ariyasu T et al. | Trehalose augments osteoprotegerin production in the FHs74Int human intestinal epithelial cell line. | 2002 | In Vitro Cell. Dev. Biol. Anim. | pmid:11963965 |
| Bateman TA and Countryman S | Osteoprotegerin and bone loss associated with spaceflight. | 2002 | Drug Discov. Today | pmid:11965392 |
| Price PA et al. | Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. | 2002 | J. Bone Miner. Res. | pmid:12096831 |
| Xing L et al. | NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. | 2002 | J. Bone Miner. Res. | pmid:12096833 |
| Zou W and Bar-Shavit Z | Dual modulation of osteoclast differentiation by lipopolysaccharide. | 2002 | J. Bone Miner. Res. | pmid:12096834 |
| Koyama H et al. | Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. | 2002 | J. Bone Miner. Res. | pmid:12096835 |
| Langdahl BL et al. | Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. | 2002 | J. Bone Miner. Res. | pmid:12096838 |
| Zhang J et al. | Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. | 2002 | J. Bone Miner. Res. | pmid:12096839 |
| Treuheit MJ et al. | Inverse relationship of protein concentration and aggregation. | 2002 | Pharm. Res. | pmid:12033388 |
| Lossdörfer S et al. | Immunohistochemical localization of receptor activator of nuclear factor kappaB (RANK) and its ligand (RANKL) in human deciduous teeth. | 2002 | Calcif. Tissue Int. | pmid:12043011 |
| Zhang J et al. | PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. | 2002 | FEBS Lett. | pmid:12067713 |
| Nakamura H et al. | Localization of osteoprotegerin (OPG) on bone surfaces and cement lines in rat tibia. | 2002 | J. Histochem. Cytochem. | pmid:12070273 |
| Brändström H et al. | A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054556 |
| Wittrant Y et al. | Osteoprotegerin differentially regulates protease expression in osteoclast cultures. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054560 |
| Penno H et al. | Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054622 |
| Fu M et al. | Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12056809 |
| Standal T et al. | Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. | 2002 | Blood | pmid:12351414 |
| Yang SY et al. | Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. | 2002 | Arthritis Rheum. | pmid:12355500 |
| Suda T et al. | [Merger of bone biology and immunology]. | 2002 | Tanpakushitsu Kakusan Koso | pmid:12385106 |
| Biskobing DM et al. | Novel therapeutic options for osteoporosis. | 2002 | Curr Opin Rheumatol | pmid:12118183 |
| Nagasawa T et al. | LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. | 2002 | Clin. Exp. Immunol. | pmid:12390325 |
| Mizukami J et al. | Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. | 2002 | Mol. Cell. Biol. | pmid:11809792 |
| Wynne F et al. | Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. | 2002 | Calcif. Tissue Int. | pmid:12073153 |
| Lubberts E et al. | Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. | 2002 | Arthritis Rheum. | pmid:12428250 |
| Crotti TN et al. | Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. | 2002 | Ann. Rheum. Dis. | pmid:12429533 |
| Hofbauer LC and Schoppet M | Osteoprotegerin deficiency and juvenile Paget's disease. | 2002 | N. Engl. J. Med. | pmid:12432053 |
| Jono S et al. | Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. | 2002 | Circulation | pmid:12208791 |
| Sedger LM et al. | Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. | 2002 | Eur. J. Immunol. | pmid:12209637 |
| Hofbauer LC et al. | Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. | 2002 | J. Cell. Biochem. | pmid:12210731 |
| Kondo H et al. | Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. | 2002 | J. Bone Miner. Res. | pmid:12211438 |
| Hofbauer LC and Schoppet M | Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12213849 |
| Arko B et al. | Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12213850 |
| Rubin J et al. | IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12213884 |
| Palmqvist P et al. | IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. | 2002 | J. Immunol. | pmid:12218157 |
| Liao EY et al. | Comparison of the effects of 17beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells. | 2002 | J. Endocrinol. Invest. | pmid:12398237 |
| Takahashi E et al. | High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture. | 2002 | J. Med. Dent. Sci. | pmid:12641381 |
| Ito S et al. | Crystal structure of the extracellular domain of mouse RANK ligand at 2.2-A resolution. | 2002 | J. Biol. Chem. | pmid:11733492 |
| Stajszczyk M | [Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism]. | 2002 | Pol. Arch. Med. Wewn. | pmid:12600190 |
| Fahrleitner A et al. | Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. | 2002 | Wien. Klin. Wochenschr. | pmid:12602117 |
| Theill LE et al. | RANK-L and RANK: T cells, bone loss, and mammalian evolution. | 2002 | Annu. Rev. Immunol. | pmid:11861618 |
| Roux S et al. | RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. | 2002 | Am. J. Clin. Pathol. | pmid:11863217 |
| Green EA et al. | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. | 2002 | Immunity | pmid:11869680 |
| Holen I et al. | Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells. | 2002 | Cancer Res. | pmid:11912131 |
| Mori H et al. | RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse. | 2002 | Histochem. Cell Biol. | pmid:11914926 |
| Scatena M and Giachelli C | The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis. | 2002 | Trends Cardiovasc. Med. | pmid:11852256 |
| Hofbauer LC and Kühne CA | Cytokine inhibition: a new therapeutic avenue for skeletal diseases. | 2002 | Drug Discov. Today | pmid:11854049 |
| Viereck V et al. | Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. | 2002 | Biochem. Biophys. Res. Commun. | pmid:11855844 |
| Romas E et al. | Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. | 2002 | Bone | pmid:11856640 |
| Viereck V et al. | Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. | 2002 | J. Cell. Biochem. | pmid:11835398 |
| Wise GE et al. | Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption. | 2002 | Arch. Oral Biol. | pmid:11839361 |
| Faucheux C et al. | Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. | 2002 | J. Bone Miner. Res. | pmid:11874237 |
| Kazama JJ et al. | Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. | 2002 | Am. J. Kidney Dis. | pmid:11877571 |
| Haas M et al. | Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. | 2002 | Am. J. Kidney Dis. | pmid:11877577 |
| Goater JJ et al. | Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. | 2002 | J. Orthop. Res. | pmid:11918293 |
| Roux S et al. | RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. | 2002 | Br. J. Haematol. | pmid:11918537 |
| Oshiro T et al. | Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. | 2002 | Anat. Rec. | pmid:11920384 |
| Redlich K et al. | Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. | 2002 | Arthritis Rheum. | pmid:11920416 |
| Cho CH and Nuttall ME | Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases. | 2002 | Expert Opin. Ther. Targets | pmid:12472380 |
| Hasegawa T et al. | Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. | 2002 | J. Periodont. Res. | pmid:12472833 |
| Yamashita T et al. | Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype. | 2002 | Endocrinology | pmid:12446599 |
| Takayanagi H | [Cross-talk between immune and skeletal systems]. | 2002 | Nippon Rinsho | pmid:12510352 |
| Shimizu-Ishiura M et al. | Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function. | 2002 | J Electron Microsc (Tokyo) | pmid:12455916 |
| Mochizuki S et al. | Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats. | 2002 | J. Bone Miner. Metab. | pmid:11810411 |
| Avbersek-Luznik I et al. | Increased levels of osteoprotegerin in hemodialysis patients. | 2002 | Clin. Chem. Lab. Med. | pmid:12476941 |
| Childs LM et al. | In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. | 2002 | J. Bone Miner. Res. | pmid:11811549 |
| Buckley KA et al. | Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. | 2002 | Bone | pmid:12477572 |
| Holloway WR et al. | Leptin inhibits osteoclast generation. | 2002 | J. Bone Miner. Res. | pmid:11811550 |
| McCauley LK and Nohutcu RM | Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy. | 2002 | J. Periodontol. | pmid:12479643 |
| Coen G et al. | Serum osteoprotegerin and renal osteodystrophy. | 2002 | Nephrol. Dial. Transplant. | pmid:11812872 |
| Bolon B et al. | Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. | 2002 | Arthritis Rheum. | pmid:12483715 |
| Golmia RP et al. | Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacós et al. | 2002 | Arthritis Rheum. | pmid:12483748 |
| Liegibel UM et al. | Concerted action of androgens and mechanical strain shifts bone metabolism from high turnover into an osteoanabolic mode. | 2002 | J. Exp. Med. | pmid:12438430 |
| Bolon B et al. | Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis. | 2002 | Cell. Mol. Life Sci. | pmid:12440777 |
| Whyte MP and Hughes AE | Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. | 2002 | J. Bone Miner. Res. | pmid:11771666 |